Phenotyping Pain in Patients With Fibrous Dysplasia/McCune-Albright Syndrome
Abstract Context Pain is a poorly managed aspect in fibrous dysplasia/McCune-Albright syndrome (FD/MAS) because of uncertainties regarding the clinical, behavioral, and neurobiological underpinnings that contribute to pain in these patients. Objective Identify neuropsychological and neurobiological...
Gespeichert in:
Veröffentlicht in: | The journal of clinical endocrinology and metabolism 2024-02, Vol.109 (3), p.771-782 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 782 |
---|---|
container_issue | 3 |
container_start_page | 771 |
container_title | The journal of clinical endocrinology and metabolism |
container_volume | 109 |
creator | Golden, Emma van der Heijden, Hanne Ren, Boyu Randall, Edin T Drubach, Laura A Shah, Nehal Cay, Mariesa Ebb, David Kaban, Leonard B Peacock, Zachary S Boyce, Alison M Mannstadt, Michael Upadhyay, Jaymin |
description | Abstract
Context
Pain is a poorly managed aspect in fibrous dysplasia/McCune-Albright syndrome (FD/MAS) because of uncertainties regarding the clinical, behavioral, and neurobiological underpinnings that contribute to pain in these patients.
Objective
Identify neuropsychological and neurobiological factors associated with pain severity in FD/MAS.
Design
Prospective, single-site study.
Patients
Twenty patients with FD/MAS and 16 age-sex matched healthy controls.
Intervention
Assessments of pain severity, neuropathic pain, pain catastrophizing (pain rumination, magnification, and helplessness), emotional health, and pain sensitivity with thermal quantitative sensory testing. Central nervous system (CNS) properties were measured with diffusion tensor imaging, structural magnetic resonance imaging, and functional magnetic resonance imaging.
Main outcome measures
Questionnaire responses, detection thresholds and tolerances to thermal stimuli, and structural and functional CNS properties.
Results
Pain severity in patients with FD/MAS was associated with more neuropathic pain quality, higher levels of pain catastrophizing, and depression. Quantitative sensory testing revealed normal detection of nonnoxious stimuli in patients. Individuals with FD/MAS had higher pain tolerances relative to healthy controls. From neuroimaging studies, greater pain severity, neuropathic pain quality, and psychological status of the patient were associated with reduced structural integrity of white matter pathways (superior thalamic radiation and uncinate fasciculus), reduced gray matter thickness (pre-/paracentral gyri), and heightened responses to pain (precentral, temporal, and frontal gyri). Thus, properties of CNS circuits involved in processing sensorimotor and emotional aspects of pain were altered in FD/MAS.
Conclusion
These results offer insights into pain mechanisms in FD/MAS, while providing a basis for implementation of comprehensive pain management treatment approaches that addresses neuropsychological aspects of pain. |
doi_str_mv | 10.1210/clinem/dgad589 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11491648</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1210/clinem/dgad589</oup_id><sourcerecordid>2874262560</sourcerecordid><originalsourceid>FETCH-LOGICAL-c340t-957708862c05bbcad71e1d078d8ff2042de899033385dff5da7e3d3493ba96883</originalsourceid><addsrcrecordid>eNqFkctLxDAQxoMo7vq4epQe9VA3rzbJSZbVVWHFBRW9hbRJdyNtWpNW6H9vZVfRkzAwh_nNN48PgBMELxBGcJKX1plqoldKJ1zsgDESNIkZEmwXjCHEKBYMv47AQQhvECJKE7IPRoRxSCHnY7BYro2r276xbhUtlXXREEvVWuPaEL3Ydh3NbebrLkRXfWhKFaya3Oezzpl4WmbertZt9Ng77evKHIG9QpXBHG_zIXieXz_NbuPFw83dbLqIc0JhG4uEsWF4inOYZFmuNEMGaci45kWBIcXacCEgIYQnuigSrZghmlBBMiVSzskhuNzoNl1WGZ0Pu3pVysbbSvle1srKvxVn13JVf0iEqEAp_VI42yr4-r0zoZWVDbkpS-XMcKvEnFGc4iSFA3qxQXNfh-BN8TMHQfnlgdx4ILceDA2nv7f7wb-fPgDnG6Dumv_EPgHPxJQQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2874262560</pqid></control><display><type>article</type><title>Phenotyping Pain in Patients With Fibrous Dysplasia/McCune-Albright Syndrome</title><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Golden, Emma ; van der Heijden, Hanne ; Ren, Boyu ; Randall, Edin T ; Drubach, Laura A ; Shah, Nehal ; Cay, Mariesa ; Ebb, David ; Kaban, Leonard B ; Peacock, Zachary S ; Boyce, Alison M ; Mannstadt, Michael ; Upadhyay, Jaymin</creator><creatorcontrib>Golden, Emma ; van der Heijden, Hanne ; Ren, Boyu ; Randall, Edin T ; Drubach, Laura A ; Shah, Nehal ; Cay, Mariesa ; Ebb, David ; Kaban, Leonard B ; Peacock, Zachary S ; Boyce, Alison M ; Mannstadt, Michael ; Upadhyay, Jaymin</creatorcontrib><description>Abstract
Context
Pain is a poorly managed aspect in fibrous dysplasia/McCune-Albright syndrome (FD/MAS) because of uncertainties regarding the clinical, behavioral, and neurobiological underpinnings that contribute to pain in these patients.
Objective
Identify neuropsychological and neurobiological factors associated with pain severity in FD/MAS.
Design
Prospective, single-site study.
Patients
Twenty patients with FD/MAS and 16 age-sex matched healthy controls.
Intervention
Assessments of pain severity, neuropathic pain, pain catastrophizing (pain rumination, magnification, and helplessness), emotional health, and pain sensitivity with thermal quantitative sensory testing. Central nervous system (CNS) properties were measured with diffusion tensor imaging, structural magnetic resonance imaging, and functional magnetic resonance imaging.
Main outcome measures
Questionnaire responses, detection thresholds and tolerances to thermal stimuli, and structural and functional CNS properties.
Results
Pain severity in patients with FD/MAS was associated with more neuropathic pain quality, higher levels of pain catastrophizing, and depression. Quantitative sensory testing revealed normal detection of nonnoxious stimuli in patients. Individuals with FD/MAS had higher pain tolerances relative to healthy controls. From neuroimaging studies, greater pain severity, neuropathic pain quality, and psychological status of the patient were associated with reduced structural integrity of white matter pathways (superior thalamic radiation and uncinate fasciculus), reduced gray matter thickness (pre-/paracentral gyri), and heightened responses to pain (precentral, temporal, and frontal gyri). Thus, properties of CNS circuits involved in processing sensorimotor and emotional aspects of pain were altered in FD/MAS.
Conclusion
These results offer insights into pain mechanisms in FD/MAS, while providing a basis for implementation of comprehensive pain management treatment approaches that addresses neuropsychological aspects of pain.</description><identifier>ISSN: 0021-972X</identifier><identifier>ISSN: 1945-7197</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/clinem/dgad589</identifier><identifier>PMID: 37804088</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Clinical</subject><ispartof>The journal of clinical endocrinology and metabolism, 2024-02, Vol.109 (3), p.771-782</ispartof><rights>The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2023</rights><rights>The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c340t-957708862c05bbcad71e1d078d8ff2042de899033385dff5da7e3d3493ba96883</cites><orcidid>0000-0003-0867-9778 ; 0000-0002-8682-163X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37804088$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Golden, Emma</creatorcontrib><creatorcontrib>van der Heijden, Hanne</creatorcontrib><creatorcontrib>Ren, Boyu</creatorcontrib><creatorcontrib>Randall, Edin T</creatorcontrib><creatorcontrib>Drubach, Laura A</creatorcontrib><creatorcontrib>Shah, Nehal</creatorcontrib><creatorcontrib>Cay, Mariesa</creatorcontrib><creatorcontrib>Ebb, David</creatorcontrib><creatorcontrib>Kaban, Leonard B</creatorcontrib><creatorcontrib>Peacock, Zachary S</creatorcontrib><creatorcontrib>Boyce, Alison M</creatorcontrib><creatorcontrib>Mannstadt, Michael</creatorcontrib><creatorcontrib>Upadhyay, Jaymin</creatorcontrib><title>Phenotyping Pain in Patients With Fibrous Dysplasia/McCune-Albright Syndrome</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>Abstract
Context
Pain is a poorly managed aspect in fibrous dysplasia/McCune-Albright syndrome (FD/MAS) because of uncertainties regarding the clinical, behavioral, and neurobiological underpinnings that contribute to pain in these patients.
Objective
Identify neuropsychological and neurobiological factors associated with pain severity in FD/MAS.
Design
Prospective, single-site study.
Patients
Twenty patients with FD/MAS and 16 age-sex matched healthy controls.
Intervention
Assessments of pain severity, neuropathic pain, pain catastrophizing (pain rumination, magnification, and helplessness), emotional health, and pain sensitivity with thermal quantitative sensory testing. Central nervous system (CNS) properties were measured with diffusion tensor imaging, structural magnetic resonance imaging, and functional magnetic resonance imaging.
Main outcome measures
Questionnaire responses, detection thresholds and tolerances to thermal stimuli, and structural and functional CNS properties.
Results
Pain severity in patients with FD/MAS was associated with more neuropathic pain quality, higher levels of pain catastrophizing, and depression. Quantitative sensory testing revealed normal detection of nonnoxious stimuli in patients. Individuals with FD/MAS had higher pain tolerances relative to healthy controls. From neuroimaging studies, greater pain severity, neuropathic pain quality, and psychological status of the patient were associated with reduced structural integrity of white matter pathways (superior thalamic radiation and uncinate fasciculus), reduced gray matter thickness (pre-/paracentral gyri), and heightened responses to pain (precentral, temporal, and frontal gyri). Thus, properties of CNS circuits involved in processing sensorimotor and emotional aspects of pain were altered in FD/MAS.
Conclusion
These results offer insights into pain mechanisms in FD/MAS, while providing a basis for implementation of comprehensive pain management treatment approaches that addresses neuropsychological aspects of pain.</description><subject>Clinical</subject><issn>0021-972X</issn><issn>1945-7197</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqFkctLxDAQxoMo7vq4epQe9VA3rzbJSZbVVWHFBRW9hbRJdyNtWpNW6H9vZVfRkzAwh_nNN48PgBMELxBGcJKX1plqoldKJ1zsgDESNIkZEmwXjCHEKBYMv47AQQhvECJKE7IPRoRxSCHnY7BYro2r276xbhUtlXXREEvVWuPaEL3Ydh3NbebrLkRXfWhKFaya3Oezzpl4WmbertZt9Ng77evKHIG9QpXBHG_zIXieXz_NbuPFw83dbLqIc0JhG4uEsWF4inOYZFmuNEMGaci45kWBIcXacCEgIYQnuigSrZghmlBBMiVSzskhuNzoNl1WGZ0Pu3pVysbbSvle1srKvxVn13JVf0iEqEAp_VI42yr4-r0zoZWVDbkpS-XMcKvEnFGc4iSFA3qxQXNfh-BN8TMHQfnlgdx4ILceDA2nv7f7wb-fPgDnG6Dumv_EPgHPxJQQ</recordid><startdate>20240220</startdate><enddate>20240220</enddate><creator>Golden, Emma</creator><creator>van der Heijden, Hanne</creator><creator>Ren, Boyu</creator><creator>Randall, Edin T</creator><creator>Drubach, Laura A</creator><creator>Shah, Nehal</creator><creator>Cay, Mariesa</creator><creator>Ebb, David</creator><creator>Kaban, Leonard B</creator><creator>Peacock, Zachary S</creator><creator>Boyce, Alison M</creator><creator>Mannstadt, Michael</creator><creator>Upadhyay, Jaymin</creator><general>Oxford University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0867-9778</orcidid><orcidid>https://orcid.org/0000-0002-8682-163X</orcidid></search><sort><creationdate>20240220</creationdate><title>Phenotyping Pain in Patients With Fibrous Dysplasia/McCune-Albright Syndrome</title><author>Golden, Emma ; van der Heijden, Hanne ; Ren, Boyu ; Randall, Edin T ; Drubach, Laura A ; Shah, Nehal ; Cay, Mariesa ; Ebb, David ; Kaban, Leonard B ; Peacock, Zachary S ; Boyce, Alison M ; Mannstadt, Michael ; Upadhyay, Jaymin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c340t-957708862c05bbcad71e1d078d8ff2042de899033385dff5da7e3d3493ba96883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Clinical</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Golden, Emma</creatorcontrib><creatorcontrib>van der Heijden, Hanne</creatorcontrib><creatorcontrib>Ren, Boyu</creatorcontrib><creatorcontrib>Randall, Edin T</creatorcontrib><creatorcontrib>Drubach, Laura A</creatorcontrib><creatorcontrib>Shah, Nehal</creatorcontrib><creatorcontrib>Cay, Mariesa</creatorcontrib><creatorcontrib>Ebb, David</creatorcontrib><creatorcontrib>Kaban, Leonard B</creatorcontrib><creatorcontrib>Peacock, Zachary S</creatorcontrib><creatorcontrib>Boyce, Alison M</creatorcontrib><creatorcontrib>Mannstadt, Michael</creatorcontrib><creatorcontrib>Upadhyay, Jaymin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Golden, Emma</au><au>van der Heijden, Hanne</au><au>Ren, Boyu</au><au>Randall, Edin T</au><au>Drubach, Laura A</au><au>Shah, Nehal</au><au>Cay, Mariesa</au><au>Ebb, David</au><au>Kaban, Leonard B</au><au>Peacock, Zachary S</au><au>Boyce, Alison M</au><au>Mannstadt, Michael</au><au>Upadhyay, Jaymin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phenotyping Pain in Patients With Fibrous Dysplasia/McCune-Albright Syndrome</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2024-02-20</date><risdate>2024</risdate><volume>109</volume><issue>3</issue><spage>771</spage><epage>782</epage><pages>771-782</pages><issn>0021-972X</issn><issn>1945-7197</issn><eissn>1945-7197</eissn><abstract>Abstract
Context
Pain is a poorly managed aspect in fibrous dysplasia/McCune-Albright syndrome (FD/MAS) because of uncertainties regarding the clinical, behavioral, and neurobiological underpinnings that contribute to pain in these patients.
Objective
Identify neuropsychological and neurobiological factors associated with pain severity in FD/MAS.
Design
Prospective, single-site study.
Patients
Twenty patients with FD/MAS and 16 age-sex matched healthy controls.
Intervention
Assessments of pain severity, neuropathic pain, pain catastrophizing (pain rumination, magnification, and helplessness), emotional health, and pain sensitivity with thermal quantitative sensory testing. Central nervous system (CNS) properties were measured with diffusion tensor imaging, structural magnetic resonance imaging, and functional magnetic resonance imaging.
Main outcome measures
Questionnaire responses, detection thresholds and tolerances to thermal stimuli, and structural and functional CNS properties.
Results
Pain severity in patients with FD/MAS was associated with more neuropathic pain quality, higher levels of pain catastrophizing, and depression. Quantitative sensory testing revealed normal detection of nonnoxious stimuli in patients. Individuals with FD/MAS had higher pain tolerances relative to healthy controls. From neuroimaging studies, greater pain severity, neuropathic pain quality, and psychological status of the patient were associated with reduced structural integrity of white matter pathways (superior thalamic radiation and uncinate fasciculus), reduced gray matter thickness (pre-/paracentral gyri), and heightened responses to pain (precentral, temporal, and frontal gyri). Thus, properties of CNS circuits involved in processing sensorimotor and emotional aspects of pain were altered in FD/MAS.
Conclusion
These results offer insights into pain mechanisms in FD/MAS, while providing a basis for implementation of comprehensive pain management treatment approaches that addresses neuropsychological aspects of pain.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>37804088</pmid><doi>10.1210/clinem/dgad589</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0003-0867-9778</orcidid><orcidid>https://orcid.org/0000-0002-8682-163X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-972X |
ispartof | The journal of clinical endocrinology and metabolism, 2024-02, Vol.109 (3), p.771-782 |
issn | 0021-972X 1945-7197 1945-7197 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11491648 |
source | Oxford University Press Journals All Titles (1996-Current) |
subjects | Clinical |
title | Phenotyping Pain in Patients With Fibrous Dysplasia/McCune-Albright Syndrome |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T23%3A50%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phenotyping%20Pain%20in%20Patients%20With%20Fibrous%20Dysplasia/McCune-Albright%20Syndrome&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=Golden,%20Emma&rft.date=2024-02-20&rft.volume=109&rft.issue=3&rft.spage=771&rft.epage=782&rft.pages=771-782&rft.issn=0021-972X&rft.eissn=1945-7197&rft_id=info:doi/10.1210/clinem/dgad589&rft_dat=%3Cproquest_pubme%3E2874262560%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2874262560&rft_id=info:pmid/37804088&rft_oup_id=10.1210/clinem/dgad589&rfr_iscdi=true |